TO NO ONE’S SURPRISE, THOSE IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS that produce molecular tests, instruments, and automation used for COVID-19 testing reported strong growth in revenue and profits during 2020. In recent weeks, these companies issued their earnings reports for the fourth quarter 2020 and full year 2020. As expected, most companies announced substantial increases …
IVD Firms Report Strong Growth Because of COVID-19 Testing Read More »
To access this post, you must purchase The Dark Report.